Camidanlumab tesirine Uses, Dosage, Side Effects and more

Camidanlumab tesirine is under investigation in clinical trial NCT04639024 (ADCT-301 in Patients With R/R AML, MDS, or MDS/MPN).

Trade Name Camidanlumab tesirine
Generic Camidanlumab tesirine
Camidanlumab tesirine Other Names Camidanlumab tesirine
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share